Citi downgraded Mindray Medical (NYSE: MR) from Buy to Hold. The firm also cut its price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE